A PHASE II MULTICENTER PROSPECTIVE STUDY OF THE TRASTUZUMAB COMBINED WITH 5-WEEKLY S-1 AND CDDP THERAPY FOR PATIENTS WITH METASTATIC OR UNRESECTABLE HER2-POSITIVE GASTRIC CANCERS. 

Kazunori Adachi  1     Hiromi Kataoka  2     Yosinori Mori  3     Satosi  Sobue     Hitosi Sano     Makoto Nakamura     Takasi Kawai     Kyouji Seno     Kunio Kasugai     Takasi Joh    
1 Department of Gastroenterology,Aichi Medical University School of Medicine,aichi,Japan;Department of Gastroenterology,Nagoya City West Medical Center,aichi ,Japan
2 Departments of Gastroenterology and Metabolism,Nagoya City University Graduate School of Medical Sciences,aichi,Japan
3 Departments of Gastroenterology and Metabolism,Nagoya Ci

Conference
UEG Week 2015

Citation
United European Gastroenterology Journal; 2015: 2 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing